Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.1 USD | +2.00% | +2.62% | -34.53% |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
Evolution of the average Target Price on Syros Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Syros Pharmaceuticals, Inc.
JMP Securities | |
Oppenheimer | |
Piper Sandler | |
HC Wainwright | |
Alliance Global Partners | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- SYRS Stock
- Consensus Syros Pharmaceuticals, Inc.